Viewing Study NCT01453920


Ignite Creation Date: 2025-12-25 @ 4:12 AM
Ignite Modification Date: 2026-04-25 @ 1:16 AM
Study NCT ID: NCT01453920
Status: COMPLETED
Last Update Posted: 2012-08-28
First Post: 2011-10-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Wet AMD Recurrence Rate in Patients Stable on Three Month Ranibizumab Dosing
Sponsor: University Health Network, Toronto
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Age Related Macular Degeneration View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Age Related Macular Degeneration View
None Choroidal Neovascular Membrane View